Literature DB >> 29281576

Prices of Generic Drugs Associated with Numbers of Manufacturers.

Chintan V Dave1, Abraham Hartzema2, Aaron S Kesselheim3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29281576     DOI： 10.1056/NEJMc1711899

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Changes in Price for Generic Drugs in the USA, 2008-2016.

Authors:  Chintan V Dave; Gregory Brill; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2019-09       Impact factor: 5.128

2.  Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.

Authors:  David G Li; Cara Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

3.  Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.

Authors:  Margaret E Helmuth; Qian Liu; Marc N Turenne; Jeong M Park; Murewa Oguntimein; Sarah K Dutcher; Rajesh Balkrishnan; Pratima Sharma; Jarcy Zee; Alan B Leichtman; Abigail R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-28       Impact factor: 8.237

4.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875

5.  Number of manufacturers and generic drug pricing from 2005 to 2017.

Authors:  Inmaculada Hernandez; Chester B Good; Walid F Gellad; Natasha Parekh; Meiqi He; William H Shrank
Journal:  Am J Manag Care       Date:  2019-07       Impact factor: 2.229

6.  Federal Spending on Off-Patent Drugs That Lack Generic Competition.

Authors:  Benjamin N Rome; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2020-03-06       Impact factor: 5.128

Review 7.  Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.

Authors:  Jing Luo; Walid F Gellad
Journal:  Curr Diab Rep       Date:  2020-01-29       Impact factor: 5.430

8.  Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Authors:  VÉronique C Raimond; William B Feldman; Benjamin N Rome; Aaron S Kesselheim
Journal:  Milbank Q       Date:  2021-03       Impact factor: 6.237

9.  Insulin access and affordability in the USA: anticipating the first interchangeable insulin product.

Authors:  Jing Luo; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  Lancet Diabetes Endocrinol       Date:  2020-03-20       Impact factor: 32.069

10.  Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Authors:  Chana A Sacks; Victor L Van de Wiele; Lisa A Fulchino; Lajja Patel; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.